Saranac Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
8,299
-3,531
-30% -$322K 0.22% 60
2026
Q1
$443K Buy
11,830
+7,495
+173% +$846K 0.19% 63
2025
Q4
$544K Buy
4,335
+225
+5% +$28.7K 0.21% 51
2025
Q3
$550K Buy
4,110
+205
+5% +$26.9K 0.1% 127
2025
Q2
$531K Buy
3,905
+155
+4% +$20.4K 0.28% 48
2025
Q1
$497K Buy
3,750
+52
+1% +$6.62K 0.28% 47
2024
Q4
$418K Sell
3,698
-550
-13% -$63.6K 0.23% 54
2024
Q3
$484K Buy
4,248
+332
+8% +$36.4K 0.73% 17
2024
Q2
$407K Buy
3,916
+55
+1% +$5.83K 0.24% 50
2024
Q1
$439K Sell
3,861
-10
-0.3% -$1.15K 0.27% 48
2023
Q4
$426K Buy
3,871
+111
+3% +$11.1K 0.28% 55
2023
Q3
$364K Hold
3,760
– – 0.2% 51
2023
Q2
$410K Hold
3,760
– – 0.22% 49
2023
Q1
$381K Buy
+3,760
New +$397K 0.22% 45

Other funds holding ABT

Saranac Partners's ABT Position: Q2 2026 in Review

Saranac Partners reduced its Abbott (ABT) stake by 30% in Q2 2026, selling an estimated $322K and leaving 8,299 shares worth $753K. The position accounts for 0.22% of the portfolio, ranked #60.

Saranac Partners first reported a position in ABT in Q1 2023 and has held it in 14 quarters since. 2,982 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Saranac Partners held 8,299 shares of Abbott worth $753K as of Q2 2026.
  • Saranac Partners sold 3,531 Abbott shares in Q2 2026, an estimated $322K.
  • Abbott made up 0.22% of Saranac Partners's portfolio in Q2 2026, its #60 holding.
  • Saranac Partners first reported a position in Abbott in Q1 2023 and has held it in 14 quarters since.
  • 2,982 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.